A quantitative investigation of the substantia nigra in Huntington's disease
- PMID: 2528318
- DOI: 10.1002/ana.410260103
A quantitative investigation of the substantia nigra in Huntington's disease
Abstract
To elucidate the quantitative and topographical changes of neurons in the substantia nigra in Huntington's disease (HD), sections from 4 HD patients and 8 age-matched control subjects were stained with cresyl violet and the numbers and localization of pigmented and nonpigmented neurons in the substantia nigra were examined. This study revealed a decrease of about 40% (p less than 0.01 or p less than 0.05) in neuronal number and a shrinkage of both pigmented and nonpigmented neurons in the substantia nigra in HD. Pigmented neuron number was decreased markedly in the ventral cell group. Loss of the neurons occurred in the medial and lateral thirds, but relative sparing of the neurons was seen in the central part of the substantia nigra. In contrast, loss of nonpigmented neurons was relatively uniform in the substantia nigra although it was more severe in the central part. We conclude that a primary neuronal degeneration occurs in the substantia nigra in HD.
Similar articles
-
Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits.Acta Neuropathol. 2007 Oct;114(4):419-24. doi: 10.1007/s00401-007-0250-5. Epub 2007 Jul 17. Acta Neuropathol. 2007. PMID: 17639428
-
Substantia nigra degeneration in motor neurone disease: a quantitative study.Aust N Z J Med. 1992 Oct;22(5):469-72. Aust N Z J Med. 1992. PMID: 1445037
-
Huntington's disease: survival of large striatal neurons in the rigid variant.Ann Neurol. 1984 Feb;15(2):154-6. doi: 10.1002/ana.410150207. Ann Neurol. 1984. PMID: 6230987
-
Neuropathology of the substantia nigra.Eur Neurol. 1991;31 Suppl 1:48-59. doi: 10.1159/000116721. Eur Neurol. 1991. PMID: 1830274 Review.
-
[Huntington disease: 7 cases with relatively preserved neostriatal islets].Rev Neurol (Paris). 1992;148(2):107-16. Rev Neurol (Paris). 1992. PMID: 1534925 Review. French.
Cited by
-
The role of dopamine in Huntington's disease.Prog Brain Res. 2014;211:235-54. doi: 10.1016/B978-0-444-63425-2.00010-6. Prog Brain Res. 2014. PMID: 24968783 Free PMC article. Review.
-
Basic and translational neuro-ophthalmology of visually guided saccades: disorders of velocity.Expert Rev Ophthalmol. 2017;12(6):457-473. doi: 10.1080/17469899.2017.1395695. Epub 2017 Nov 28. Expert Rev Ophthalmol. 2017. PMID: 30774705 Free PMC article.
-
Screening of therapeutic strategies for Huntington's disease in YAC128 transgenic mice.CNS Neurosci Ther. 2012 Jan;18(1):77-86. doi: 10.1111/j.1755-5949.2011.00246.x. CNS Neurosci Ther. 2012. PMID: 21501423 Free PMC article. Review.
-
Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice.J Comp Neurol. 2021 May 1;529(7):1327-1371. doi: 10.1002/cne.25023. Epub 2020 Sep 20. J Comp Neurol. 2021. PMID: 32869871 Free PMC article.
-
Selective loss of nigral neurons in Pick's disease: a morphometric study.Acta Neuropathol. 1990;81(2):155-61. doi: 10.1007/BF00334504. Acta Neuropathol. 1990. PMID: 2082655
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical